Skip to content
10-Q

Quarterly Report

EnzymeBioSystems

0001493152-18-002385

← back to feed
Filed
Feb 21, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Feb 20, 2018 5.59M sh
Operating Cash Flow Q2 2018 · Dec 31, 2017 −$170.05K
Operating Cash Flow Q2 2018 · Dec 31, 2016 −$62.41K
Cash And Equivalents Q2 2018 · Dec 31, 2017 $427.16K
Cash And Equivalents Q2 2018 · Jun 30, 2017 $41.25K
Cash And Equivalents Q2 2018 · Dec 31, 2016 $77.63K
Cash And Equivalents Q2 2018 · Jun 30, 2016 $140.04K
Stockholders Equity Q2 2018 · Dec 31, 2017 −$422.56K
Stockholders Equity Q2 2018 · Jun 30, 2017 $40.15K
Current Liabilities Q2 2018 · Dec 31, 2017 $10.6K
Current Liabilities Q2 2018 · Jun 30, 2017 $4.1K
Total Liabilities Q2 2018 · Dec 31, 2017 $10.6K
Total Liabilities Q2 2018 · Jun 30, 2017 $4.1K
Current Assets Q2 2018 · Dec 31, 2017 $433.16K
Current Assets Q2 2018 · Jun 30, 2017 $44.25K
Total Assets Q2 2018 · Dec 31, 2017 $433.16K
Total Assets Q2 2018 · Jun 30, 2017 $44.25K
Net Income Q2 2018 · Dec 31, 2017 −$546.1K
Net Income Q2 2018 · Dec 31, 2017 −$571.55K
Net Income Q2 2018 · Dec 31, 2016 −$29.08K
Net Income Q2 2018 · Dec 31, 2016 −$56.58K
Operating Income Q2 2018 · Dec 31, 2017 −$546.4K
Operating Income Q2 2018 · Dec 31, 2017 −$572.25K
Operating Income Q2 2018 · Dec 31, 2016 −$29.08K
Operating Income Q2 2018 · Dec 31, 2016 −$56.58K